How to build a start-up: Launching early stage science companies
UKI2S, Catapult Ventures and Jonathan Milner invest £500K in gene modulation newcomer Pencil Biosciences
Policy leaders share ambitious vision for increased R&D investment post-election
Spin out secures £1.1M for ground-breaking ‘supercharged’ cell therapies to treat solid tumours
Rapid test for gonorrhoea and chlamydia to be developed by University of Birmingham spinout
Expert Interview with Gilad Gershon: Selecting the right talent for your start-up
UKI2S wins Best Sector Support Organisation at the OBN Awards
Helping to Maximise the Economic Impact of the UK's Scientific Research
We work with our partners to turn the UK's world class research into global products and services.
ZuvaSyntha is developing proprietary renewable manufacturing routes to industrial chemicals from low cost feedstocks such as syngas and methanol.
Its lead program…